U.S. Professional Services Stock News

NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

ArcBest (ARCB) Valuation Check After Recent Share Price Momentum

What ArcBest’s Recent Returns Signal For Investors ArcBest (ARCB) has attracted attention after a strong recent run, with the stock showing around 21% return over the past month and about 62% over the past 3 months, prompting fresh interest in its fundamentals. See our latest analysis for ArcBest. That recent burst of momentum, with a 30 day share price return of about 21% and 90 day share price return of roughly 62% from a latest share price of $106.03, contrasts with a more modest 1 year...
NYSE:JMIA
NYSE:JMIAMultiline Retail

Assessing Jumia Technologies (JMIA) Valuation After Q4 2025 Results And Profitability Push

Jumia Technologies (JMIA) just posted its fourth quarter and full year 2025 earnings, reporting sales of US$61.4 million for the quarter and a reduced net loss of US$10.31 million. See our latest analysis for Jumia Technologies. The earnings release comes after a sharp pullback in the 30 day share price return of 29.47% and a weaker year to date share price return of 23.69%. However, the 1 year total shareholder return of 144.14% and 3 year total shareholder return of 134.21% still point to...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

Should Mercury Systems’ Record H1 Revenue and Narrower Losses Prompt Action From MRCY Investors?

In early February 2026, Mercury Systems reported second-quarter fiscal 2026 results showing sales of US$232.87 million versus US$223.13 million a year earlier, with net loss narrowing to US$15.10 million and basic loss per share from continuing operations improving to US$0.26 from US$0.30. Management emphasized that record first-half revenue was supported by faster hardware shipments, strong booking activity, and new higher-margin program wins, even as a low-margin backlog is expected to...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Verra Mobility’s NYC Camera Deal And What It May Mean For Valuation

Verra Mobility secured a new five year contract with the New York City Department of Transportation to expand and manage automated enforcement camera programs. The agreement broadens red light and bus lane safety coverage across all five boroughs and adds technology upgrades and community focused commitments. The contract extends a long running relationship between Verra Mobility and NYC DOT and is tied to legislatively supported program growth. For investors watching Verra Mobility,...
NYSE:NEXA
NYSE:NEXAMetals and Mining

Is It Time To Reassess Nexa Resources (NEXA) After Its 123% One-Year Surge?

If you are wondering whether Nexa Resources at around US$12.38 is still attractively priced after a strong run, you are not alone. This article is built to help you frame that value question clearly. The stock has had a mixed short term patch with a 3.1% decline over the last 7 days, but it also shows returns of 15.3% over 30 days, 40.8% year to date, 122.9% over 1 year and 95.9% over 3 years, as well as 43.4% over 5 years. Recent moves are taking place against a backdrop of continuing...
NasdaqGS:DDOG
NasdaqGS:DDOGSoftware

Is Datadog (DDOG) Pricing Reflect Its DCF Upside After Recent Share Price Weakness

If you are wondering whether Datadog’s current share price matches its long term potential, you are not alone. This article focuses squarely on what you might be paying versus what you are getting. Datadog’s share price closed at US$127.33, with returns of 10.0% over the past week, 0.6% over the past month, a 4.8% decline year to date and a 14.0% decline over the past year, set against a 43.5% and 23.5% return over the past 3 and 5 years respectively. Recent market attention on Datadog has...
NYSE:AMP
NYSE:AMPCapital Markets

Ameriprise Legal Dispute Raises Questions For Advisor Relations And Valuation

Ameriprise Financial (NYSE:AMP) is in a legal dispute with LPL Financial involving advisor transitions and data access. A federal appeals court has allowed a group of advisors to intervene in the case and pause searches of their personal devices. The ruling is tied to ongoing FINRA arbitration, which is shaping how evidence and advisor rights are handled. Ameriprise Financial, trading at about $485.96, enters this dispute with a mixed return profile, including a 44.7% gain over 3 years and...
NYSE:CNC
NYSE:CNCHealthcare

Will Shift From 2025 Losses to 2026 Profit Guidance Change Centene's (CNC) Narrative

In early February 2026, Centene Corporation reported fourth-quarter 2025 revenue of US$49.73 billion and a net loss of US$1.10 billion, with full-year 2025 revenue of US$194.78 billion and a net loss of US$6.67 billion. Alongside these results, Centene issued 2026 guidance calling for total revenue of US$186.50 billion to US$190.50 billion and GAAP diluted EPS of more than US$1.98, while highlighting margin improvement efforts and mixed membership trends across Medicaid and Commercial...
NYSE:CCL
NYSE:CCLHospitality

A Look At Carnival Corporation (CCL) Valuation After Earnings Surprises And New Fleet Agreements

Carnival Corporation & (CCL) earnings surprises and operations in focus Carnival Corporation & (CCL) is back on investor radars after four straight quarters of positive earnings surprises, alongside fresh fleet wide operational agreements and new port development projects that spotlight ongoing business adjustments. See our latest analysis for Carnival Corporation &. Despite a small 1 day share price pullback, Carnival’s 90 day share price return of 26.59% and 1 year total shareholder return...
NasdaqGS:EXLS
NasdaqGS:EXLSProfessional Services

EXL Patents New AI Data Tools As Shares Trade Below Targets

ExlService Holdings (NasdaqGS:EXLS) has received 10 new U.S. patents covering AI and data-focused solutions. The patents span multiple sectors, including insurance, healthcare, retail, utilities, and financial services. Newly protected capabilities target data readiness for AI, workflow automation, and tuning large language models for enterprise use. For shareholders watching NasdaqGS:EXLS, this patent batch lands after a challenging stretch for the stock, with the share price at $30.25 and...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Gen Digital (GEN) Is Up 7.6% After Q3 Beat And AI Agent Trust Hub Launch - What's Changed

Gen Digital Inc. recently reported third-quarter fiscal 2026 results, with sales rising to US$1,240 million and net income to US$192 million year on year, while also declaring a quarterly dividend of US$0.125 per share payable on March 11, 2026. Alongside these results, the company launched its Gen Agent Trust Hub to address emerging security risks from autonomous AI agents, signaling an effort to position its cyber safety platform at the center of the AI “agentic” ecosystem. We’ll now...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Why Illumina (ILMN) Is Down 12.9% After 2026 Outlook And SomaLogic Deal Close - And What's Next

In early February 2026, Illumina reported fourth-quarter 2025 revenue of US$1,159 million and full-year 2025 revenue of US$4.34 billion, issued 2026 revenue guidance of US$4.5–4.6 billion, and closed its SomaLogic acquisition. At the same time, Illumina expanded its role in clinical and conservation genomics, including a sequencing agreement for up to 4,000 Frozen Zoo® samples with the San Diego Zoo Wildlife Alliance. Now we’ll examine how Illumina’s 2026 guidance, including the SomaLogic...
NYSE:IT
NYSE:ITIT

Gartner Refocuses As G2 Buys Capterra And Other Review Platforms

Gartner (NYSE:IT) is selling its software review platforms Capterra, Software Advice, and GetApp to G2. The deal shifts ownership of three widely used B2B software discovery sites to a single operator in the sector. This transaction marks a change in Gartner's portfolio mix and reduces its direct exposure to software review marketplaces. For you as an investor, this move matters because Gartner has been known for both its research and its role in software buying decisions through these...
NasdaqGS:UPWK
NasdaqGS:UPWKProfessional Services

Upwork’s AI And Enterprise Pivot Tests Growth Hopes And Valuation Discount

Upwork (NasdaqGS:UPWK) is integrating its Lifted enterprise platform into the core business while stepping up investment in artificial intelligence tools and services. The company recently reported financial results that showed weaker active client metrics and issued cautious guidance for the next quarter. Management highlighted AI driven impacts on pricing and transaction volumes as key headwinds alongside the shift toward a more enterprise focused model. These moves have raised questions...
NYSE:CNS
NYSE:CNSCapital Markets

Cohen And Steers ETF Shift Tests Valuation Premium And Dividend Support

Cohen & Steers plans to convert its Future of Energy Fund into an ETF. The shift aligns the firm with a broader move by traditional asset managers toward ETF structures. The conversion responds to changing investor preferences around access, fees, and trading flexibility. Cohen & Steers, listed as NYSE:CNS, is moving its Future of Energy Fund into an ETF format at a time when investors are paying close attention to listed asset managers and their product line ups. The shares most recently...
NasdaqGS:VRSN
NasdaqGS:VRSNIT

Does VeriSign (VRSN) Leaning on Dividends and Buybacks Reframe Its Core Growth Narrative?

VeriSign, Inc. recently reported its fourth-quarter and full-year 2025 results, showing higher sales and net income year over year, while also announcing a quarterly dividend increase to US$0.81 per share and updating investors on progress under its long-running share repurchase program. Beyond the headline growth in revenue and earnings, the combination of a higher dividend and continued buybacks highlights management’s emphasis on returning cash to shareholders alongside its core internet...
NasdaqGS:PSKY
NasdaqGS:PSKYMedia

Assessing Paramount Skydance (PSKY) Valuation After Recent Share Price Weakness And Undervaluation Signals

Paramount Skydance (PSKY) has caught investor attention after its recent performance, with the share price last closing at US$11.01 and short term returns showing a mix of modest gains and declines across different time frames. See our latest analysis for Paramount Skydance. Those small recent share price gains, including a 1-day share price return of 1.57% and 7-day return of 2.42%, sit against a weaker backdrop, with a 30-day share price return showing a 9.38% decline and a 90-day share...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Is Neurocrine Biosciences (NBIX) Pricing Reflecting Its Strong 1 Year Share Performance?

If you are wondering whether Neurocrine Biosciences is fairly priced or offering value right now, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$137.44, with returns of 3.6% over 30 days and 17.3% over 1 year. These figures can change how investors think about both its potential upside and its risk. Recent news coverage has focused on Neurocrine Biosciences as a key player in the US pharmaceuticals and biotech space, with...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Is It Time To Reassess Atlassian (TEAM) After A 73% Share Price Slide

If you are wondering whether Atlassian shares are starting to look interesting at today’s price, this article will walk through what the current market value actually reflects and what it might be missing. Atlassian’s share price closed at US$86.97, with returns of a 17.2% decline over 7 days, 40.6% decline over 30 days, 43.8% decline year to date and 72.7% decline over the past year. Even the 3 year and 5 year returns of 53.6% decline and 65.3% decline respectively show how much sentiment...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Is It Time To Reassess Syndax Pharmaceuticals (SNDX) After A 46% One Year Share Price Gain?

If you are wondering whether Syndax Pharmaceuticals at US$21.71 is offering good value today, you are not alone. This article is here to unpack that question calmly and clearly. The stock has returned 6.3% over the last 7 days, 4.8% over 30 days, 1.9% year to date and 46.1% over the past year. However, the 3 year and 5 year returns of negative 16.5% and negative 5.0% show a more mixed longer term picture. These moves have arrived alongside ongoing interest in Syndax Pharmaceuticals' pipeline...
NYSE:AVTR
NYSE:AVTRLife Sciences

Avantor (AVTR) Q3 Loss Of US$711.8 Million Tests Bullish Earnings Narratives

How Avantor's FY 2025 Numbers Set the Stage for the Next Chapter Avantor (AVTR) just posted its FY 2025 third quarter results with revenue of US$1,623.8 million, a basic EPS loss of US$1.04 and net income loss of US$711.8 million, putting a sharp spotlight on profitability. The company has seen quarterly revenue move from US$1,714.4 million in Q3 2024 to US$1,686.6 million in Q4 2024, then to US$1,581.4 million and US$1,683.4 million in Q1 and Q2 2025, with EPS shifting from US$0.08 to...
NasdaqGM:NVTS
NasdaqGM:NVTSSemiconductor

A Look At Navitas Semiconductor (NVTS) Valuation After New 10 kW AI Data Center Power Platform Launch

Navitas Semiconductor (NVTS) has introduced a 10 kW all‑GaN DC‑DC power platform targeting next‑generation AI data centers, offering up to 98.5% peak efficiency, 1 MHz switching frequency, and high power density in a compact full‑brick module. See our latest analysis for Navitas Semiconductor. At a share price of $8.76, Navitas has had a mixed few months, with a 7 day share price return of 6.83% alongside a 30 day share price decline of 16.01%. Its 1 year total shareholder return of 207.37%...
NasdaqGS:CASH
NasdaqGS:CASHBanks

Is It Time To Reassess Pathward Financial (CASH) After Recent Share Price Strength?

If you are wondering whether Pathward Financial's current share price still offers value, it helps to first see how its market price lines up with what the business might be worth. The stock last closed at US$89.59, with returns of 21.8% over the past month, 24.7% year to date and 14.0% over the last year, which can change how investors think about both upside and risk. Recent news coverage has focused on Pathward Financial's position in the U.S. banking sector and how its business model...
NYSE:NU
NYSE:NUBanks

Is It Too Late To Consider Nu Holdings (NU) After A 232% Three Year Surge?

If you are wondering whether Nu Holdings is still good value after its strong run, you are not alone. The stock has quickly become a talking point for many growth focused investors. The share price recently closed at US$17.41, with total returns of 2.3% over the past week, 2.2% over the past month, 2.3% year to date and 27.6% over the last year, while the 3 year return sits at 232.3%. This naturally raises questions about what is already priced in. Recent news flow has centered on Nu...